美女高潮喷水白浆后入在线观看_出a级黑粗大硬长爽猛视频_qvod日韩伦理电影_亚洲自偷自拍三级_成人黄片视频_精品综合无码在线观看_亚洲综合无码中文字幕伊人_亚洲男人天堂最新版_夫洗澡公强我了60分钟_免费看又爽又黄又猛的视频

糖抗原125(CA125)多克隆抗體(異硫氰酸熒光素標記)

FITC-Linked Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)

MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125

  • 糖抗原125(CA125)多克隆抗體(異硫氰酸熒光素標記) 產品包裝(模擬)
  • 糖抗原125(CA125)多克隆抗體(異硫氰酸熒光素標記) 產品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質量體系認證

特異性

該抗體是針對CA125的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CA125。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學:5-20μg/mL;1:25-100
免疫細胞化學:5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。

贈品

相關產品

編號 適用物種:Homo sapiens (Human,人) 應用(僅供研究使用,不用于臨床診斷!)
URPA154Hu01 糖抗原125(CA125)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPA154Hu02 糖抗原125(CA125)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAA154Hu01 糖抗原125(CA125)多克隆抗體 WB; IHC
UPAA154Hu02 糖抗原125(CA125)多克隆抗體 WB; IHC; ICC; IP.
ULAA154Hu81 糖抗原125(CA125)多克隆抗體(異硫氰酸熒光素標記) WB; IHC; ICC; IF.
ULAA154Hu71 糖抗原125(CA125)多克隆抗體(生物素標記) WB; IHC; ICC.
UMAA154Hu22 糖抗原125(CA125)單克隆抗體 WB; IHC; ICC; IP.
USEA154Hu 糖抗原125(CA125)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMA154Hu 糖抗原125(CA125)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
UKSA154Hu01 糖抗原125(CA125)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志 參考文獻
PLoS One Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. [pubmed:27755542]
Tumor Biology KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis [pubmed:28651492]
Oncotarget Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer [Pubmed:29484129]
Prognostic value of STC1 expression in ovarian cancer []
American Journal of Translational Research Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway [Pubmed:35422913]
留言咨詢